Surgical management of colorectal cancer.pptxHamSayshi1
油
Surgical treatment of Colorectal Cancer Current Treatment Guidelines 2024...A reveiw of literature
palliative management of CRC and Mechanical bowel preparation in case of CRC alongwith Treatment guidleines of grade 4 CRC in presence of metastasis
1. Explain the physiological control of glomerular filtration and renal blood flow
2. Describe the humoral and autoregulatory feedback mechanisms that mediate the autoregulation of renal plasma flow and glomerular filtration rate
Non-Invasive ICP Monitoring for NeurosurgeonsDhaval Shukla
油
This presentation delves into the latest advancements in non-invasive intracranial pressure (ICP) monitoring techniques, specifically tailored for neurosurgeons. It covers the importance of ICP monitoring in clinical practice, explores various non-invasive methods, and discusses their accuracy, reliability, and clinical applications. Attendees will gain insights into the benefits of non-invasive approaches over traditional invasive methods, including reduced risk of complications and improved patient outcomes. This comprehensive overview is designed to enhance the knowledge and skills of neurosurgeons in managing patients with neurological conditions.
Invasive systems are commonly used for monitoring intracranial pressure (ICP) in traumatic brain injury (TBI) and are considered the gold standard. The availability of invasive ICP monitoring is heterogeneous, and in low- and middle-income settings, these systems are not routinely employed due to high cost or limited accessibility. The aim of this presentation is to develop recommendations to guide monitoring and ICP-driven therapies in TBI using non-invasive ICP (nICP) systems.
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...KHUSHAL CHAVAN
油
This presentation provides an in-depth understanding of solubilization and its critical role in pharmaceutical formulations. It covers:
Definition & Mechanisms of Solubilization
Role of surfactants, micelles, and bile salts in drug solubility
Factors affecting solubilization (pH, polarity, particle size, temperature, etc.)
Methods to enhance drug solubility (Buffers, Co-solvents, Surfactants, Complexation, Solid Dispersions)
Advanced approaches (Polymorphism, Salt Formation, Co-crystallization, Prodrugs)
This resource is valuable for pharmaceutical scientists, formulation experts, regulatory professionals, and students interested in improving drug solubility and bioavailability.
Presentaci坦 que va acompanyar la demostraci坦 prctica de metge d'Innovaci坦 Jos辿 Ferrer sobre el projecte Benestar de BSA, nom d'IDIAP Pere Gol, el 5 de mar巽 de 2025 a l'estand de XarSMART al Mobible Word Congress.
Surgical management of colorectal cancer.pptxHamSayshi1
油
Surgical treatment of Colorectal Cancer Current Treatment Guidelines 2024...A reveiw of literature
palliative management of CRC and Mechanical bowel preparation in case of CRC alongwith Treatment guidleines of grade 4 CRC in presence of metastasis
1. Explain the physiological control of glomerular filtration and renal blood flow
2. Describe the humoral and autoregulatory feedback mechanisms that mediate the autoregulation of renal plasma flow and glomerular filtration rate
Non-Invasive ICP Monitoring for NeurosurgeonsDhaval Shukla
油
This presentation delves into the latest advancements in non-invasive intracranial pressure (ICP) monitoring techniques, specifically tailored for neurosurgeons. It covers the importance of ICP monitoring in clinical practice, explores various non-invasive methods, and discusses their accuracy, reliability, and clinical applications. Attendees will gain insights into the benefits of non-invasive approaches over traditional invasive methods, including reduced risk of complications and improved patient outcomes. This comprehensive overview is designed to enhance the knowledge and skills of neurosurgeons in managing patients with neurological conditions.
Invasive systems are commonly used for monitoring intracranial pressure (ICP) in traumatic brain injury (TBI) and are considered the gold standard. The availability of invasive ICP monitoring is heterogeneous, and in low- and middle-income settings, these systems are not routinely employed due to high cost or limited accessibility. The aim of this presentation is to develop recommendations to guide monitoring and ICP-driven therapies in TBI using non-invasive ICP (nICP) systems.
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...KHUSHAL CHAVAN
油
This presentation provides an in-depth understanding of solubilization and its critical role in pharmaceutical formulations. It covers:
Definition & Mechanisms of Solubilization
Role of surfactants, micelles, and bile salts in drug solubility
Factors affecting solubilization (pH, polarity, particle size, temperature, etc.)
Methods to enhance drug solubility (Buffers, Co-solvents, Surfactants, Complexation, Solid Dispersions)
Advanced approaches (Polymorphism, Salt Formation, Co-crystallization, Prodrugs)
This resource is valuable for pharmaceutical scientists, formulation experts, regulatory professionals, and students interested in improving drug solubility and bioavailability.
Presentaci坦 que va acompanyar la demostraci坦 prctica de metge d'Innovaci坦 Jos辿 Ferrer sobre el projecte Benestar de BSA, nom d'IDIAP Pere Gol, el 5 de mar巽 de 2025 a l'estand de XarSMART al Mobible Word Congress.
Flag Screening in Physiotherapy Examination.pptxBALAJI SOMA
油
Flag screening is a crucial part of physiotherapy assessment that helps in identifying medical, psychological, occupational, and social barriers to recovery. Recognizing these flags ensures that physiotherapists make informed decisions, provide holistic care, and refer patients appropriately when necessary. By integrating flag screening into practice, physiotherapists can optimize patient outcomes and prevent chronicity of conditions.
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsKHUSHAL CHAVAN
油
This presentation provides a comprehensive overview of optimization in pharmaceutical formulations. It explains the concept of optimization, different types of optimization problems (constrained and unconstrained), and the mathematical principles behind formulation development. Key topics include:
Methods for optimization (Sequential Simplex Method, Classical Mathematical Methods)
Statistical analysis in optimization (Mean, Standard Deviation, Regression, Hypothesis Testing)
Factorial Design & Quality by Design (QbD) for process improvement
Applications of optimization in drug formulation
This resource is beneficial for pharmaceutical scientists, R&D professionals, regulatory experts, and students looking to understand pharmaceutical process optimization and quality by design approaches.
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxdrnidhimnd
油
The shoulder complex acts as in coordinated fashion to provide the smoothest and greatest range of motion possible of the upper limb.
Combined motion of GH and ST joint of shoulder complex helps in:
Distribution of motion between other two joints.
Maintenance of glenoid fossa in optimal position.
Maintenance of good length tension
Although some amount of glenohumeral motion may occur while the other shoulder articulations remain stabilized, movement of the humerus more commonly involves some movement at all three shoulder joints.
Chair and Presenters Sara A. Hurvitz, MD, FACP, Carey K. Anders, MD, FASCO, and Vyshak Venur, MD, discuss metastatic HER2-positive breast cancer in this CME/NCPD/CPE/AAPA/IPCE activity titled Fine-Tuning the Selection and Sequencing of HER2-Targeting Therapies in HER2-Positive MBC With and Without CNS Metastases: Expert Guidance on How to Individualize Therapy Based on Latest Evidence, Disease Features, Treatment Characteristics, and Patient Needs and Preferences. For the full presentation, downloadable Practice Aids, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4f8sUs7. CME/NCPD/CPE/AAPA/IPCE credit will be available until March 2, 2026.
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the FutureSteve Jennings
油
Creatine burst into the public consciousness in 1992 when an investigative reporter inside the Olympic Village in Barcelona caught wind of British athletes using a product called Ergomax C150. This led to an explosion of interest in and questions about the ingredient after high-profile British athletes won multiple gold medals.
I developed Ergomax C150, working closely with the late and great Dr. Roger Harris (1944 2024), and Prof. Erik Hultman (1925 2011), the pioneering scientists behind the landmark studies of creatine and athletic performance in the early 1990s.
Thirty years on, these are the slides I used at the Sports & Active Nutrition Summit 2025 to share the story, the lessons from that time, and how and why creatine will play a pivotal role in tomorrows high-growth active nutrition and healthspan categories.
legal Rights of individual, children and women.pptxRishika Rawat
油
A legal right is a claim or entitlement that is recognized and protected by the law. It can also refer to the power or privilege that the law grants to a person. Human rights include the right to life and liberty, freedom from slavery and torture, freedom of opinion and expression, the right to work and education
Best Sampling Practices Webinar USP <797> Compliance & Environmental Monito...NuAire
油
Best Sampling Practices Webinar USP <797> Compliance & Environmental Monitoring
Are your cleanroom sampling practices USP <797> compliant? This webinar, hosted by Pharmacy Purchasing & Products (PP&P Magazine) and sponsored by NuAire, features microbiology expert Abby Roth discussing best practices for surface & air sampling, data analysis, and compliance.
Key Topics Covered:
鏝 Viable air & surface sampling best practices
鏝 USP <797> requirements & compliance strategies
鏝 How to analyze & trend viable sample data
鏝 Improving environmental monitoring in cleanrooms
・ Watch Now: https://www.nuaire.com/resources/best-sampling-practices-cleanroom-usp-797
Stay informedfollow Abby Roth on LinkedIn for more cleanroom insights!
3. Presented in OPD with complain of:
Prominent veins on both legs for 3 years
Swelling and pain in the lower limbs for 1 year
Ulcer on the right lower limb for 1 month
4. HOPI
According to the patient , he started noticing prominent veins in his lower limbs 3-4 years back,
more on the right side.The veins gradually became more dilated , especially after prolonged
standing.
He also complained of pain and swelling in both limbs for 1 year.The pain was gradual in onset,
and progressive in nature.The patient described a dragging feeling which worsens when the
patient stands for a long time and relieves after rest.The pain is non-radiating and not relieved
with pain killers.
He also presented with an ulcer on the right lower limb for 1 month. It occurred spontaneously
and initially was small in size.The size increased with time.There was no history of trauma.
There is also complain of itching over the lower limb
5. There is no history of constipation, chronic cough, pain abdomen or fever.
His bowel and bladder habits are regular.
No history suggestive of DVT in the past.
No history of smoking.
Newly diagnosed hypertention ( not taking any medication)
6. Past surgical history: not significant
No family history of varicose veins.
7. GENERAL PHYSICAL EXAMINATION
The patient was a morbidly obese male, conscious and oriented to time ,place and
person.
No pallor, icterus, cyanosis, clubbing, lymphedema noted.
VITALS:
BP: 160/90
Pulse : 98 bpm
Weight: 181 kg
8. INSPECTION:
Patient was examined in standing position
Long, tortuous and dilated veins seen extending from above the medial malleolus to above the knee.
Skin of the right lower leg was hyperpigmented and thickened.
There is eczema over the medial malleolus.
An ulcer was noticed over the medial aspect of the right lower limb.Approx. 4*3 cm in size with irregular
sloping margins, floor covered with scab. Seropurulent discharge noted from the ulcer, scanty in amount and
non foul smelling.
Redness noted over the right foot extending to the ankle.
9. Palpation:
No tenderness noted,
Sloping edge is felt with irregular margins. Depth approx.2mm
The ulcer does not bleed on touch.
Temperature of the right foot was raised as compared to the left.
Peripheral pulses were palpable.
Abdominal exam: unremarkable
11. INVESTIGATION
Colour Doppler: showed incompetent sapheno-femoral and
sapheno-popliteal junction.
Incompetant perforators also noted below the knee joint and above
the ankle region.
Gross subcutaneous edema in lower part of the leg.
No evidence of DVT
The accompanying arteries showed normal triphasic blood flow.
12. MANAGEMENT:
Multilayer compressive dressing done to decrease
the venous hypertention.
Antibiotic treatment started for treatment of
cellulitis
Plan of EVLA / Foam Sclerotherapy after the
infection settles down .
13. VARICOSE VEINS
Varicose veins are enlarged, swollen,
and tortous veins, usually occurring in
the legs.
They result from weakened or
damaged valves in the veins, leading
to poor blood circulation and the
appearance of bulging, blue or purple
veins.
14. ANATOMY
Deep system of veins; Lie below the deep fascia
Superficial system of veins; lie above the deep fascia eg great and short saphenous vein
Perforating veins; connect superficial and deep venous system, they perforate deep fascia,
Guarded by valves; unidirectional blood flow from superficial to deep venous system
Locations
Dodd: mid-thigh prforators
Boyd; Gestrocnemius perforator
Cocket (I-III) lower leg perforators
May or Kuster;Ankle perforators
17. EPIDEMIOLOGY
The adult prevalence of visible varicose veins is between 30% and 50%. Factors affecting
prevalence include:
Gender: the vast majority of studies report a higher prevalence in women than men
Age: the prevalence of varicose veins increases with age
Ethnicity
Body mass and height: increasing body mass index and height associated with a higher
prevalence of varicose veins.
Pregnancy: increases the risk of varicose veins.
18. EPIDEMIOLOGY
Family history: evidence supports familial susceptibility to varicose veins.
Occupation and lifestyle factors: there is inconclusive evidence regarding increased
prevalence of varicose veins in smokers, patients who suffer constipation and occupations
that involve prolonged standing.
20. SYMPTOMS
Varicose veins frequently cause symptoms.
Patients describe aching, heaviness, throbbing, burning or
bursting over affected areas and sometimes the whole limb.
Such symptoms typically increase throughout the day or with
prolonged standing,
and are relieved by elevation or compression hosiery.
There may be pruritus, pedal edema, pigmentation, dermatitis,
ulceration, tenderness, Compagne-bottle deformity,
lipodermatosclerosis
21. SIGNS
The presence of tortuous dilated subcutaneous veins is usually clinically
obvious.
These are confined to the GSV and SSV systems in approximately 60% and 20% of
cases, respectively.
medial thigh and calf varicosities suggest GSV incompetence and posterolateral
calf varicosities are suggestive of SSV incompetence
SAPHENAVARIX; a large, usually painless lump in the groin which becomesVisible
and prominent on standing and coughing and disappear in recumbent position
22. CLINICAL CLASSIFICATIONS OFVARICOSEVEINS
C0; no visible or palpable signs of venous disease
C1; Telangiectasia, reticular veins or malleolar flare
C2; varicose veins
C3; Edema without skin changes
C4; Skin changes due to venous disease like
C4a; Pigmentation
C4b; lipodermatosclerosis
C5; skin changes as above with healed ulceration
C6; skin changes as above with active ulceration
24. CEAP CLASSIFICATION
Clinical signs (Grade 1 to 6) supplemented by A for asymptomatic and S for symptomatic
Etiologic classification; Congenital, primary, secondary (post-thrombotic)
Anatomic distribution (Superficial, deep or perforators alone or in combination)
pathophysiologic classification (reflux or obstruction alone or in combination)
25. REGIONAL CLASSIFICATION
Great saphenous vein (60%) Medial thigh and calf
Small saphenous vein (20%) Posterolateral calf
Anterior (accessory) saphenous vein; isolated anterolateral thigh and calf
Saphena varix; Large dilated painless lump at saphenofemoral junction which is emergent
on standing and coughing and disappear in recumbent position
27. INVESTIGATIONS
Duplex ultrasound scanning; Investigation of choice
The aim is to establish:
the presence of refux in the deep and superfcial venous system;
the exact distribution and extent of refux in the superfcial venous system
the presence of obstruction in the deep venous system;
the presence of thrombus within the superfcial veins;
an indication of a pelvic source of reflux or obstruction
29. TREATMENT
Conservative therapy (compression)
Avoidance of long standing
1. Elastic crepe bandage from below upwards or use of pressure stockings
2. Elevation of limbs
3. Pneumatic compression
30. TREATMENT
2. Endothermal ablation; (gold standard)
A Catheter is inserted into the incompetent axial vein percutaneously.The vein is surrounded by
tumescent local anaesthetic solution.This compresses the vein onto the treatment device, emptying it of
blood.
The catheter then produces thermal energy that destroys the structure of the vein, resulting in
permanent occlusion.
Two broad technologies exist:
1. Endovenous laser ablation (EVLA)
2. Radiofrequency Ablation (RFA)
31. TREATMENT
1. Endovenous laser ablation (EVLA)
It utilises a small flexible glass fibre that is inserted into the vein. Laser energy (typically at
a wavelength of 1470nm) is transmitted down the fibre
2. Radio-frequency ablation (RFA)
It uses the same treatment principles, but an electromagnetic current is used to create
the thermal energy
There have been a range of studies comparing EVLA and RFA.The evidence is generally
equivocal, with both treatments having relative advantages and disadvantages;
choice often comes down to personal preference.
Both are excellent treatment options and can be applied successfully to the majority of
patients.
32. TREATMENT
1. Ultrasound guided foam sclerotheraphy
It involves the injection of a sclerosing agent directly into the superficial veins.
The most commonly used is sodium tetradecyl sulphate.
The direct contact with detergent causes cellular death and initiates an
inflammatory response, aiming to result in thrombosis, fibrosis and obliteration
(sclerosis).
2. Catheter directed sclerotheraphy
3. Catheter directed mechanicochemical ablation
The catheter is placed within the vein lumen as for endothermal ablation,
spinning wire causes physical damage to the endothelium and allows a deeper
penetration of the sclerosant into the vein wall.
33. TREATMENT
Endovenous glue (cyanoacrelate gel)
Catheter based, A handle is used to infiltrate the
adhesive in 0.1mL applications via the catheter. The
vein is then compressed, sealing the lumen closed.
35. TREATMENT
Open surgeries
The principles of traditional ligation and stripping are to fully
dissect the point of junctional incompetence and to remove the
refluxing axial vein and dilated tributaries.
1. Saphenofemoral junction ligation and great saphenous stripping
2. Saphenopopliteal junction ligation and small saphenous stripping
37. TREATMENT
Complications of surgery
Complications (minor and major) are reported in up to 20% of patients who undergo traditional varicose vein
surgery.
1.Wound infections, are the most common complication
2.Nerve injury is the most common serious complication
. saphenous nerve neuralgia is up to 7% following GSV stripping to the knee
The incidence of sural nerve neuropraxia and common peroneal nerve injury may be as high as 20% and 4%,
respectively, following SSV surgery.
3.The incidence of venous thromboembolic complications is approximately 0.5% following varicose vein surgery
39. VENOUS ULCER
Venous disease is responsible for around
85% of all chronic lower limb ulcers.
Community-based prevalence is 0.10.3%
in adults (24% in the elderly).
40. MANAGEMENT
The keystone of management is to decrease venous hypertension using
venous ablation and compression therapy.
The most clinical and cost-efective compression regimes are two-layer
compression hosiery or four-layer compression bandaging.
41. The latter includes:
Orthopaedic wool: distributes the pressure and reduces undue pressure on sensitive areas
susceptible to pressure damage.Also helps to absorb excess exudate that escapes the primary
dressing.
Cotton crepe: smooths the wool and holds it in place.
Elastic bandage: frst compressive layer, contributes about one-third of the interface pressure.
Cohesive bandage: second compressive layer, increases stifness and adds approximately two-
thirds of the interface pressure